Safety and Tolerability Study of NBI-98854 for the Treatment of Tardive Dyskinesia
Clinical trial NCT02405091 · COMPLETED
Trial details
- NCT number
- NCT02405091
- Sponsor
- Neurocrine Biosciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2017-03-01
- Enrollment
- 167
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.